Feedback
Settings

Settings

Goto Application

1. WO2006123829 - ANTIBODY DIRECTED AGAINST PAP2a AND USE THEREOF FOR DIAGNOSTIC AND THERAPEUTIC PURPOSES

PermaLink
Publication Number WO/2006/123829
Publication Date 23.11.2006
International Application No. PCT/JP2006/310406
International Filing Date 17.05.2006
IPC
C12N 15/00 2006.01
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
15Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
A61K 39/395 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39Medicinal preparations containing antigens or antibodies
395Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
A61P 35/00 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
35Antineoplastic agents
C07K 16/40 2006.01
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
16Immunoglobulins, e.g. monoclonal or polyclonal antibodies
40against enzymes
C12N 5/10 2006.01
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
5Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
10Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells
C12N 15/09 2006.01
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
15Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
09Recombinant DNA-technology
CPC
A61K 2039/505
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39Medicinal preparations containing antigens or antibodies
505comprising antibodies
A61P 35/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
35Antineoplastic agents
A61P 35/04
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
35Antineoplastic agents
04specific for metastasis
C07K 16/2803
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
16Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
18against material from animals or humans
28against receptors, cell surface antigens or cell surface determinants
2803against the immunoglobulin superfamily
C07K 16/2884
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
16Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
18against material from animals or humans
28against receptors, cell surface antigens or cell surface determinants
2884against CD44
C07K 16/40
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
16Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
40against enzymes
Applicants
  • SAPPORO MEDICAL UNIVERSITY [JP]/[JP] (AllExceptUS)
  • 濱田 洋文 HAMADA, Hirofumi [JP]/[JP] (UsOnly)
  • 中村 公則 NAKAMURA, Kiminori [JP]/[JP] (UsOnly)
  • 加藤 和則 KATO, Kazunori [JP]/[JP] (UsOnly)
Inventors
  • 濱田 洋文 HAMADA, Hirofumi
  • 中村 公則 NAKAMURA, Kiminori
  • 加藤 和則 KATO, Kazunori
Agents
  • 小林 浩 KOBAYASHI, Hiroshi
Priority Data
2005-14380117.05.2005JP
2005-20206911.07.2005JP
Publication Language Japanese (JA)
Filing Language Japanese (JA)
Designated States
Title
(EN) ANTIBODY DIRECTED AGAINST PAP2a AND USE THEREOF FOR DIAGNOSTIC AND THERAPEUTIC PURPOSES
(FR) ANTICORPS DIRIGE CONTRE PAP2a ET SON UTILISATION DANS DES BUTS DE DIAGNOSTIC ET THERAPEUTIQUES
(JA) ＰＡＰ２ａに対する抗体ならびにその診断的および治療的使用
Abstract
(EN)
The purpose is to develop a gene delivery system which has a high selectivity to a target cell and can introduce and express a gene with high efficiency, particularly to develop such a system for use in a gene delivery therapy using a viral vector. A method for targeting a drug, the method comprising the step of delivering a drug containing a therapeutic gene to a target site using an anti-PAP2a antibody.
(FR)
Système de délivrance de gène qui a une sélectivité élevée pour une cellule cible et qui peut introduire et exprimer un gène avec une efficacité élevée, en particulier système pour une utilisation dans une thérapie de délivrance de gène en utilisant un vecteur viral; et procédé pour le ciblage d’un médicament, le procédé comprenant l’étape de délivrance d’un médicament contenant un gène thérapeutique à un site cible en utilisant un anticorps anti-PAP2a.
(JA)
本発明は、標的細胞に対して高い選択性を有しかつ高効率で遺伝子を導入及び発現できるような、遺伝子導入システムを開発すること、特に、ウイルスベクターを用いた遺伝子導入療法において、上記システムの開発をすることを目的とする。本発明は、抗ＰＡＰ２ａ抗体を用いて、治療遺伝子を含む薬剤を標的部位へ送達することを包含する、薬剤の標的指向化方法を提供する。
Also published as
EP1908825
US20090214421
JPWO2006123829
JP2008163029
Latest bibliographic data on file with the International Bureau
# -